Global Economic Outlook - February 2021

Economic research

  • Algeria,
  • Angola,
  • Argentina,
  • Australia,
  • Austria,
  • Bangladesh,
  • Belgium,
  • Brazil,
  • Bulgaria,
  • Canada,
  • Chile,
  • China,
  • Colombia,
  • ,
  • Croatia,
  • ,
  • Czech Republic,
  • Denmark,
  • Egypt,
  • Estonia,
  • Finland,
  • France,
  • Germany,
  • Greece,
  • Hong Kong,
  • Hungary,
  • Iceland,
  • India,
  • Indonesia,
  • Iran,
  • Ireland,
  • Italy,
  • Japan,
  • Jordan,
  • Kenya,
  • Kuwait,
  • Latvia,
  • Lithuania,
  • Luxembourg,
  • Malaysia,
  • Mexico,
  • Morocco,
  • Netherlands,
  • New Zealand,
  • Norway,
  • ,
  • Peru,
  • Philippines,
  • Poland,
  • Portugal,
  • Romania,
  • Russia,
  • Saudi Arabia,
  • Singapore,
  • Slovakia,
  • Slovenia,
  • South Africa,
  • South Korea,
  • Spain,
  • Sweden,
  • Switzerland,
  • Taiwan,
  • Tanzania,
  • Thailand,
  • Tunisia,
  • Turkey,
  • United Arab Emirates,
  • USA,
  • United Kingdom,
  • Vietnam
  • General economic

4th February 2021

As several vaccines have been approved and are being rolled out, we expect the global economy to rebound in 2021

After a major downturn of the global economy in 2020 caused by the Covid-19 pandemic and despite renewed lockdowns in some parts of the world, there we expect the global economy to rebound in 2021. Several vaccines have been approved and are in the process of being rolled out, allowing for a gradual reversal of lockdown measures. Meanwhile fiscal and monetary support remains essential while countries return to normal economic life. There is considerable uncertainty around our baseline forecast, given the possibility of a delayed recovery, which may occur if there is a stretched wave of global infections. This would significantly reduce GDP growth in 2021 and effectively push the recovery into 2022.

Key points

  • As countries gradually emerge from their lockdowns, we expect global GDP to recover by 5.0% in 2021, following a 3.9% contraction in 2020.
  • Prospects for global trade in 2021 are good, following a revival of trade growth in the second half of last year. Global trade growth is expected to rebound by 7-8% in 2021, after a contraction of similar size in 2020.
  • After economic downturns in 2020, advanced markets as a group see growth rebounding by 3.9% in 2021, after a 5.0% decline in 2020. The pace of recovery deviates, but most advanced markets do not completely recover in 2021 from the GDP contraction they experienced last year.
  • In the Eurozone, economies continue to be in relatively strict lockdowns. A partial recovery of 4.2% is likely to occur in 2021 and only in 2022 is activity expected to return to pre-pandemic levels. National governments are expected to continue fiscal stimulus well into 2021.
  • The virus poses serious downside risks to the US economy in 2021, but economic growth is forecast to rebound as the rollout of vaccination allows lockdown measures to be gradually reversed. Moreover, the new government reduces policy uncertainty, and a new major stimulus plan for the economy is in the making.
  • In Japan, infections were brought under control in the first half of 2020. As a result, the economy is off to a good start in 2021, though it will not fully recover from the recession of last year. If held, the Tokyo Olympics will provide a temporary boost to GDP in 2021.
  • Many emerging market economies (EMEs) are still at a critical stage in the health crisis, though there are large differences between countries and regions. Asia is head of the curve in controlling the number of infections. Emerging markets as a group are forecast to grow by 6.3% in 2021, following a 1.9% contraction in 2020.

Related documents

Disclaimer

Each publication available on or from our websites, such as, but not limited to webpages, reports, articles, publications, tips and helpful content, trading briefs, infographics, videos (each a “Publication”) is provided for information purposes only and is not intended as a recommendation or advice as to particular transactions, investments or strategies in any way to any reader. Readers must make their own independent decisions, commercial or otherwise, regarding the information provided. While we have made every attempt to ensure that the information contained in any Publication has been obtained from reliable sources, Atradius is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in any Publication is provided ’as is’, with no guarantee of completeness, accuracy, timeliness or of the results obtained from its use, and without warranty of any kind, express or implied. In no event will Atradius, its related partnerships or corporations, or the partners, agents or employees thereof, be liable to you or anyone else for any decision made or action taken in reliance on the information in any Publication, or for any loss of opportunity, loss of profit, loss of production, loss of business or indirect losses, special or similar damages of any kind, even if advised of the possibility of such losses or damages.